FRI0403 HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION


Creative Commons License

MİCHELSEN B., OMBJERG L., LOFT A. G. , JOSEPH S., CLUREA A., MANN H., ...More

EULAR 2019, Madrid, Spain, 12 - 14 June 2019, vol.78, pp.887-888 identifier